Skip to main content


Peter Sonnenreich; Bassem Wolley; and Katherine Moody, Contributing Writers
Certain comorbidities—particularly congestive heart failure, tuberculosis, and HIV infection—can affect the type of psoriasis treatment physicians recommend to their patients.
Jonathan Silverberg, MD
Several studies showed associations between atopic dermatitis and various diseases and conditions, from depression to cardiovascular disease. Here is how dermatologists can translate the latest evidence on comorbidities into practice.
Jill Waldbieser, Managing Editor
Itch is one of the most common—and distressing—symptoms of atopic dermatitis, and effectively treating it requires an understanding of the underlying pathology of the disease.
Jill Waldbieser, Managing Editor
Although rosacea affects patients with skin of color at lower rates, those incidences may be underreported. To change that, dermatologists need to improve diagnostic accuracy for these patients.
Melissa Weiss, Associate Editor
Dermatologists have another weapon in their arsenal to prescribe for patients with mild plaque psoriasis.
Jill Waldbieser, Managing Editor
Research has barely scratched the surface of what we can learn about the relationships between immunity and inflammatory skin disease. A leading expert discusses the implications of emerging and future research on managing AD.
Wasim Haidari, BS, BA, and Steven R. Feldman, MD, PhD
Although these drugs frequently are highly effective at treating psoriasis, prescribing them is only half the battle. Dermatologists and patients both face other challenges to access.
Jill Waldbieser, Managing Editor
A leading expert on how food affects skin weighs in on dietary triggers and ways to manage them.
Peter Sonnenreich, Bassem Wolley, Katherine Moody, and Linda Geisler; Contributing Writers
About 30% of patients with psoriasis will develop this chronic, inflammatory comorbidity. Knowing how to recognize and treat it can help improve patient outcomes.
Jill Waldbieser, Managing Editor
Despite a burgeoning body of research about AD’s causes, symptoms, and novel treatments for the disease, some myths stubbornly persist among clinicians.
Back to Top